New test to deduce diabetes risk in polycystic ovary syndrome sufferers

Scientists at the University of Birmingham have uncovered a new method to identify and test women with polycystic ovary syndrome who are at high risk of going onto develop diabetes.

The findings will pave the way for a more personalized approach to the treatment and management of PCOS, with women who have the risk factors for developing type 2 diabetes being selectively tested for the disease and offered early therapeutic interventions to reduce long-term health risks.

Full Article

<-- FDA Delays Final OK for Type 2 Drug Empagliflozin

Fighting Diabetes' Deadly Impact on Minorities -->